Industry Focus Areas, Medical, Regulations
October 24, 2018
Via: Mass DeviceXeris Pharmaceuticals (NSDQ:XERS) said today that the FDA accepted its new drug application for a ready-to-use liquid glucagon rescue pen device. The company’s product is designed to treat severe hypoglycemia in people with diabetes. The FDA is slated to make […]
July 9, 2024
June 25, 2024